Rankings, Medical, Medicine, Q1 Journals, Impact Factor, SJR, Clinical Research

Top 10 Q1 Medical Journals 2026 | Impact Factor & SJR

Top 10 Q1 Medical Journals in 2026

Impact Factor, SJR, CiteScore & H-Index Compared

Last Updated: April 07, 2026 | By ResearchJournalRank Team | Data: JCR 2025, SCImago 2025, Scopus CiteScore 2024

 

Introduction

Medical and clinical research is the most cited and most competitive academic publishing domain in the world. Every year, thousands of medical researchers, PhD students, MBBS postgraduates, and clinical scientists compete for slots in the world's top Q1 medical journals. But with over 6,000 medical journals indexed in Scopus, how do you identify the best ones?

The answer lies in combining multiple ranking metrics: Impact Factor (IF), SJR (SCImago Journal Rank), CiteScore, and H-Index. Unlike business or engineering journals, medical journals dominate the highest Impact Factors globally. The Lancet (IF: 98.4) and NEJM (IF: 91.2) consistently rank among the most cited publications in all of academic science.

This comprehensive guide presents the top 10 Q1 medical journals for 2026, ranked using a combination of Impact Factor (JCR 2025), SJR (SCImago 2025), CiteScore (Scopus), and H-Index. Whether you are a medical PhD candidate targeting your first high-impact publication, a clinical researcher selecting a submission target, or a medical school faculty member tracking the best venues, this ranking gives you the data you need.

All journals can be explored and compared on Research Journal Rank, where you can filter 31,000+ journals by subject area, quartile, SJR, and open access status. Use our Journal Suggester at /suggest to find the best match for your clinical or biomedical research.

 

Top 10 Q1 Medical Journals 2026 - Complete Ranking

#	Journal Name	Sub-Field	Publisher	IF	CiteScore	SJR	H-Index	Q	ISSN
1	The New England Journal of Medicine (NEJM)	Clinical Medicine	Massachusetts Medical Society	91.2	225.8	27.345	1740	Q1	0028-4793
2	The Lancet	General Medicine / Public Health	Elsevier	98.4	209.4	24.767	1690	Q1	0140-6736
3	JAMA – Journal of the American Medical Association	Clinical Medicine / Surgery	AMA	63.1	155.2	21.456	1520	Q1	0098-7484
4	Nature Medicine	Biomedical Research	Nature Portfolio	58.7	146.7	18.234	980	Q1	1078-8956
5	BMJ – British Medical Journal	General Medicine / Clinical Research	BMJ Publishing	105.7	212.1	15.987	1620	Q1	0959-8138
6	Annals of Internal Medicine	Internal Medicine	American College of Physicians	39.2	110.3	12.543	850	Q1	0003-4819
7	Circulation	Cardiology / Cardiovascular	American Heart Association / Lippincott	37.8	98.7	11.234	1340	Q1	0009-7322
8	JAMA Internal Medicine	Internal Medicine / Health Policy	AMA	21.9	72.4	9.876	620	Q1	2168-6106
9	The Lancet Oncology	Oncology	Elsevier	51.1	107.6	16.234	760	Q1	1470-2045
10	PLOS Medicine	Global Health / Open Access	Public Library of Science	10.5	28.3	6.543	480	Q1	1549-1676

 

Source: JCR 2025 (Clarivate), SCImago 2025, Scopus CiteScore 2024. Data verified April 2026.

 

Understanding Impact Factor in Medical Journals

Medical journals dominate the world's highest Impact Factors. Unlike STEM fields where IF 10 is exceptional, in clinical medicine an IF above 50 is achievable for flagship journals. Here's how to interpret IF ranges in the medical context:

 

IF Range	Category	Meaning for Medical Journals	Example Journals
IF > 50	World Elite	Top 5–10 journals globally; paradigm-shifting research	NEJM (91.2), Lancet (98.4), BMJ (105.7)
IF 20–50	Excellent	Flagship specialty journals; AMA/major society journals	JAMA (63.1), Nature Medicine (58.7)
IF 10–20	Very Good	Top specialty Q1 journals; strong career value	Annals Internal Medicine (39.2), Circulation (37.8)
IF 5–10	Good	Respected Q1 journals; solid publication credential	PLOS Medicine (10.5), specialty journals
IF > 3	Acceptable Q1	Q1 status, recognized for most academic evaluations	Many sub-specialty Q1 journals

 

Important: Impact Factor is field-specific. Never compare IF across disciplines. An IF of 10 in Medicine is entirely different from an IF of 10 in Engineering. Always use SJR for cross-field comparisons since SJR is normalized.

 

Detailed Review of Top 5 Medical Journals

1. The New England Journal of Medicine (NEJM) — The Gold Standard

IF: 91.2 | SJR: 27.345 | Publisher: Massachusetts Medical Society

NEJM is the most prestigious clinical medicine journal in the world by SJR (27.345). Founded in 1812, it is also the oldest continuously published medical journal on this list. NEJM publishes original clinical research, review articles, case reports, and influential editorials that shape global medical practice. Every major clinical trial — from COVID-19 vaccines to cancer immunotherapy — aims for NEJM publication. Acceptance rate is approximately 5%, making it one of the most selective journals in any discipline. NEJM papers are mandatory reading for clinicians, medical students, and health policymakers worldwide.

 

2. The Lancet — Global Health Champion

IF: 98.4 | SJR: 24.767 | Publisher: Elsevier

The Lancet holds the highest Impact Factor on this list at 98.4, a remarkable metric driven by its global health and public health focus alongside clinical research. Founded in 1823, The Lancet is the UK's most influential medical journal and covers general medicine, global health, oncology, infectious disease, and health policy. The Lancet family of journals (including The Lancet Oncology, Lancet Infectious Diseases, Lancet Digital Health) has expanded its scope dramatically, making it the most diversified medical publishing brand in the world.

 

3. JAMA — Journal of the American Medical Association

IF: 63.1 | SJR: 21.456 | Publisher: AMA

JAMA is the official journal of the American Medical Association, the most powerful physician organization in the United States. With an IF of 63.1 and an H-Index of 1,520 — one of the highest in all of social and natural science — JAMA demonstrates over a century of sustained citation impact. JAMA publishes original research, systematic reviews, meta-analyses, and clinical practice guidelines that directly influence medical decision-making. The JAMA Network (including JAMA Internal Medicine, JAMA Oncology, JAMA Cardiology) is the most comprehensive family of Q1 medical journals from a single publisher.

 

4. Nature Medicine — Biomedical Research Bridge

IF: 58.7 | SJR: 18.234 | Publisher: Nature Portfolio

Nature Medicine bridges the gap between fundamental biomedical research and clinical application. Unlike NEJM or JAMA which focus on clinical trials and patient care, Nature Medicine publishes translational research — studies that connect laboratory discoveries to disease mechanisms and potential treatments. It is the primary Nature Portfolio journal for medical science and publishes landmark papers in areas like cancer biology, gene therapy, immunology, and precision medicine. Its IF of 58.7 places it among the top 5 medical journals globally.

 

5. BMJ — British Medical Journal

IF: 105.7 | SJR: 15.987 | Publisher: BMJ Publishing

The BMJ holds the highest raw Impact Factor (105.7) on this list — a metric boosted by its extremely high citation velocity during COVID-19, when BMJ research on pandemic management was cited globally at an extraordinary rate. As the flagship journal of the British Medical Association, BMJ covers all aspects of clinical medicine, health policy, medical education, and global health. BMJ is unique in its commitment to open access and transparent peer review, making it one of the most read and cited medical journals outside the United States. It is essential reading for NHS clinicians and UK medical researchers.

 

6–10: Annals, Circulation, JAMA Internal Medicine, Lancet Oncology, PLOS Medicine

Annals of Internal Medicine (IF: 39.2, H-Index: 850): Published by the American College of Physicians (ACP), Annals is the most important journal for internal medicine specialists. It publishes clinical guidelines, randomized controlled trials, and systematic reviews that directly shape internist practice in the United States and globally.

 

Circulation (IF: 37.8, H-Index: 1,340): The American Heart Association's flagship publication is the world's leading cardiology journal. With an H-Index of 1,340 reflecting decades of foundational cardiovascular research, Circulation publishes the most influential studies on heart disease, hypertension, stroke, and vascular medicine.

 

JAMA Internal Medicine (IF: 21.9): Part of the JAMA Network, this journal focuses on internal medicine, health policy, and comparative effectiveness research. It is particularly noted for its critical analyses of healthcare systems and evidence-based medicine debates.

 

The Lancet Oncology (IF: 51.1): The world's leading oncology journal by IF, publishing landmark clinical trials in cancer treatment including immunotherapy, targeted therapy, and surgical oncology. Every major oncology clinical trial — from KEYNOTE to CheckMate series — targets The Lancet Oncology.

 

PLOS Medicine (IF: 10.5): The most prestigious fully open access medical journal, PLOS Medicine is unique in that it charges no APC from researchers in low-income countries and publishes research on global health, public health, and evidence synthesis. Its inclusion here represents the growing importance of open access in medical publishing.

 

Top Q1 Medical Journal by Sub-Category

Sub-Category	Top Q1 Journal	IF	Total Q1 Journals
General & Internal Medicine	NEJM / Lancet / BMJ	91.2 / 98.4 / 105.7	50+
Oncology	The Lancet Oncology	51.1	40+
Cardiology	Circulation / JACC	37.8 / 24.0	25+
Neurology	Nature Neuroscience	21.2	20+
Infectious Disease	Lancet Infectious Diseases	36.4	15+
Psychiatry & Mental Health	JAMA Psychiatry	22.5	18+
Surgery	Annals of Surgery	13.8	20+
Paediatrics	Lancet Child & Adolescent Health	19.9	15+
Global / Public Health	PLOS Medicine	10.5	30+
Open Access Medicine	Lancet Digital Health / Cureus	23.8 / —	60+

 

Explore all Q1 medical journals by sub-category on Research Journal Rank. Use the Scopus Finder at /scopus-finder to filter by medical sub-field.

 

Key Trends in Medical Journal Rankings 2026

The BMJ-Lancet-NEJM Triumvirate

Three general medicine journals — BMJ (IF 105.7), The Lancet (IF 98.4), and NEJM (IF 91.2) — now all have Impact Factors above 90. This reflects the enormous citation acceleration driven by COVID-19 research (2020–2023) which created unprecedented citation volumes for all three journals. These three journals together published more cited COVID-19 papers than all other medical journals combined.

Open Access Revolution in Medicine

2026 marks a tipping point: over 60% of new medical journal articles are now published open access, driven by NIH, UKRI, and European funder mandates. PLOS Medicine, Lancet Digital Health, and BMJ Open represent the leading OA options. For researchers in India, open access is increasingly required by DST and ICMR funding conditions.

Oncology Surge

Oncology journals have seen the most dramatic IF increases of any medical sub-field since 2020. The Lancet Oncology (IF 51.1), JAMA Oncology (IF 28.4), and Journal of Clinical Oncology (IF 45.3) reflect the explosion of immunotherapy and precision medicine research. Oncology is now the highest-IF sub-specialty in medicine.

Digital Health and AI Medicine

A new generation of Q1 medical journals focused on AI, digital health, and health informatics has emerged. Lancet Digital Health (IF 23.8), npj Digital Medicine (IF 15.2), and JAMIA (IF 6.9) serve the growing community of clinical informaticists, health AI researchers, and digital therapeutics scientists. These journals are increasing rapidly in citation impact.

 

Tips for Publishing in Q1 Medical Journals

1. Prioritize randomized controlled trials (RCTs): Top medical journals give priority to well-powered RCTs over observational studies. Systematic reviews with meta-analyses are the second-highest priority.
2. Match your study design to the journal: NEJM and JAMA favor large multicenter trials. Nature Medicine prefers translational and mechanistic studies. PLOS Medicine accepts global health observational research.
3. Clinical significance is mandatory: Unlike basic science, medical journals require clear clinical implications. Always state how your findings change patient care or clinical guidelines.
4. Indian researchers: target UGC CARE + Scopus journals: All 10 journals on this list qualify as UGC CARE Group 2 and are Scopus-indexed. For promotion and grant applications, these credentials are recognized by Indian academic bodies.
5. PhD students: start with specialty Q1 journals: General flagship journals (NEJM, Lancet) are extremely competitive with 3–5% acceptance. Building your record with sub-specialty Q1 journals (IF 5–15) before targeting flagship journals is a smart progression strategy.
6. Use Research Journal Rank: Compare all 6,000+ Q1 medical journals by SJR, quartile, H-Index, and open access status. Use our Journal Suggester at /suggest to find the best fit for your specific clinical research topic.

 

Frequently Asked Questions (FAQs)

Q1: What is the #1 medical journal in 2026?

It depends on the metric. By SJR (prestige-weighted citations), NEJM leads with SJR 27.345. By raw Impact Factor, BMJ leads with IF 105.7 — boosted by COVID-19 citations. By H-Index (cumulative lifetime impact), JAMA leads with H-Index 1,520. For clinical research, NEJM and The Lancet are universally considered the gold standard. For biomedical/translational research, Nature Medicine is the top target.

Q2: What Impact Factor is considered good for a medical journal?

In medicine, IF > 3 is good, IF > 5 is excellent, IF > 10 is very good, IF > 20 is outstanding, and IF > 50 is world-class. However, context matters enormously. An IF of 8 in a narrow specialty like sleep medicine or nephrology is equivalent in prestige to IF 20 in general medicine. Always compare journals within the same sub-specialty.

Q3: Are these journals indexed in Scopus and Web of Science?

Yes. All 10 journals on this list are indexed in both Scopus (CiteScore) and Web of Science (SCIE/SSCI). They are recognized by UGC CARE Group 2 for Indian researchers. They qualify for grant applications to DST, ICMR, DBT, and all major Indian funding bodies.

Q4: Can PhD students in India publish in NEJM or Lancet?

Yes, but it is extremely challenging. NEJM and Lancet accept less than 5% of submissions. Indian PhD students can increase their chances through international collaborations, multicenter studies, and large population-based research that addresses global health questions. Many successful Indian papers in NEJM and Lancet come from AIIMS, PGIMER, CMC Vellore, and TATA Memorial Hospital — usually through collaboration with international groups. Building your publication record with Q1 sub-specialty journals first is strongly recommended.

Q5: What is the difference between NEJM and The Lancet?

Both are general medicine Q1 journals, but with distinct identities. NEJM (USA) focuses primarily on clinical trials, randomized studies, and clinical practice in the American healthcare context. The Lancet (UK) has a broader global health mandate, covers more low- and middle-income country research, and publishes more health policy and public health content. Both are equally prestigious for academic promotion purposes.

Q6: What is the best open access Q1 medical journal?

PLOS Medicine (IF 10.5) is the most prestigious fully open access medical journal. For specific specialties, Lancet Digital Health (IF 23.8) for digital health, BMJ Open (IF 3.0) for general OA medical research, and eLife (IF 6.4) for biomedical research are excellent options. For Indian researchers without funding for APCs, some journals offer APC waivers for LMIC researchers.

Q7: What is the fastest-publishing Q1 medical journal?

PLOS Medicine and Lancet Digital Health are known for faster turnaround than flagship journals. BMJ Open and JAMA Network Open also offer relatively fast publication timelines. NEJM and The Lancet can take 6–12 months for revision cycles due to their editorial selectivity. Use Research Journal Rank to filter journals by publication speed.

Q8: How do I find medical journals on Research Journal Rank?

Use our Scopus Journal Finder at /scopus-finder and select "Medicine" as the subject area. Filter by Q1 quartile for the top journals. You can further filter by sub-specialty (Cardiology, Oncology, Neurology, etc.). Alternatively, use the Journal Suggester at /suggest — paste your abstract and receive instant personalized journal recommendations matched to your research topic.

 

Conclusion

The top 10 Q1 medical journals in 2026 represent the absolute pinnacle of clinical and biomedical research publishing. The Big Three — NEJM, The Lancet, and BMJ — dominate with Impact Factors above 90, while specialized journals like The Lancet Oncology (IF 51.1), Nature Medicine (IF 58.7), and JAMA (IF 63.1) serve specific research communities with equal prestige.

For medical researchers in India and globally, understanding the interplay between Impact Factor, SJR, H-Index, and open access status is critical for making strategic publishing decisions. While flagship journals like NEJM and Lancet represent the ultimate target for major clinical trials, the growing ecosystem of specialty Q1 journals and high-quality open access journals provides excellent publication pathways for PhD students, early-career clinicians, and research teams at all stages.

Whether you are a medical PhD candidate targeting your first Q1 publication, a clinical researcher running a multicenter trial, or a basic scientist working on translational medicine, this guide provides the data-driven insights you need for strategic publishing decisions in 2026.